• AMPK’s Dual Role in Autophagy Regulation: Rethinking ULK1 Co

  2026-05-13

  This article reviews recent evidence demonstrating that AMPK suppresses, rather than activates, autophagy via inhibition of ULK1. The findings redefine a central paradigm in autophagy signaling and offer practical considerations for researchers dissecting energy stress responses.

• Transdermal Delivery of PTEN mRNA via HA-LNPs for Melanoma T

  2026-05-13

  This study introduces a hyaluronate-conjugated lipid nanoparticle (HA-LNP) platform for non-invasive, transdermal delivery of PTEN mRNA, targeting melanoma. The findings demonstrate restoration of tumor suppressor function, enhanced immune activation, and significant tumor growth inhibition, highlighting a clinically relevant advance for localized cancer immunotherapy.

• Lipidated Nanophotosensitizers Target Tumor Extracellular Ve

  2026-05-12

  This study introduces a lipidated nanophotosensitizer that traces and disables tumor extracellular vesicles (TEVs), concurrently inhibiting tumor growth and metastasis in preclinical models. The approach enables synchronous photodynamic disruption of both primary tumors and TEV-mediated communication, marking an advance in selective antimetastatic strategies.

• Mubritinib (TAK 165): Advancing AML & PEL Research Workflows

  2026-05-12

  Mubritinib (TAK 165) is redefining mitochondrial targeting in cancer research, enabling highly selective workflows for acute myeloid leukemia (AML) and primary effusion lymphoma (PEL) with robust cytotoxicity against resistant subtypes. This article guides researchers through optimized protocols and troubleshooting for integrating Mubritinib into advanced experimental setups.

• Practical Guidance: Annexin V-FITC/7-AAD Apoptosis Kit (K113

  2026-05-11

  The Annexin V-FITC/7-AAD Apoptosis Kit enables researchers to rapidly and sensitively dissect apoptotic versus necrotic cell populations in established phosphatidylserine-binding workflows. It is best suited for use in flow cytometry or fluorescence microscopy-based cell death and cytotoxicity assays, and is not designed for mechanistic or pathway-specific research outside standard apoptosis detection.

• Efficient Purification of Recombinant Annexin V for Biophysi

  2026-05-11

  This study introduces a rapid and effective method for purifying recombinant annexin V, a calcium-dependent phospholipid-binding protein, using a combination of osmotic shock, calcium-mediated liposome binding, and ion-exchange chromatography. The protocol addresses challenges in protein purity essential for advanced biophysical analyses, offering a valuable resource for researchers in membrane protein and ion channel studies.

• Serum Enhances Gamithromycin Potency Against Caprine Mastiti

  2026-05-10

  This study rigorously evaluated the in vitro susceptibility of major caprine mastitis pathogens to four antibiotics, with a focus on how serum supplementation alters macrolide efficacy. The findings reveal that physiological conditions significantly increase Gamithromycin's potency, which has direct implications for both experimental design and clinical protocol development.

• HOXC8 Suppresses Pyroptosis via Caspase-1 Downregulation in

  2026-05-09

  This study reveals that HOXC8, a homeobox transcription factor, suppresses pyroptotic cell death in non-small cell lung carcinoma (NSCLC) by downregulating caspase-1 expression. The work uncovers a mechanistic link between HOXC8, histone deacetylase recruitment, and regulation of inflammatory cell death, providing new insights into tumorigenesis and potential intervention points.

• BMS-777607 (SKU A5703): Advancing Kinase Inhibition in Plate

  2026-05-08

  This article explores real-world laboratory scenarios where BMS-777607 (SKU A5703), a selective c-Met inhibitor, resolves key challenges in cell viability, proliferation, and cytotoxicity assays. Through scenario-driven analysis, bench scientists gain actionable insights into protocol optimization, data interpretation, and reliable sourcing, all grounded in validated performance metrics and literature evidence.

• BRD4 Inhibitors Enhance Erastin-Induced Ferroptosis via ROS

  2026-05-08

  This study demonstrates that BRD4 inhibition, using agents such as I-BET-762, significantly sensitizes diverse cell lines to erastin-induced ferroptosis through mechanisms involving ROS accumulation and FSP1 downregulation. The findings provide mechanistic insight for leveraging BET inhibitors as adjuncts to ferroptosis inducers in cancer biology research.

• COX-2 Pathway Roles in Ischemia and Revascularization Post-V

  2026-05-07

  This study clarifies the dual, time-dependent role of the cyclooxygenase-2 (COX-2) pathway in skeletal muscle injury induced by Bothrops asper venom. Early COX-2 inhibition exacerbated limb ischemia, while delayed inhibition promoted angiogenic signaling and revascularization, revealing key temporal windows for therapeutic intervention.

• ECL Chemiluminescent Substrate Detection Kit: Workflow, Tips

  2026-05-07

  The ECL Chemiluminescent Substrate Detection Kit (Hypersensitive) delivers low picogram sensitivity and extended signal duration for robust immunoblotting of low-abundance proteins. This guide details optimized protocols, troubleshooting strategies, and how innovations from recent metabolic research translate into practical western blot workflows.

• Redox-Responsive Peptide Coacervates Advance mRNA Delivery

  2026-05-06

  This study introduces HBpep-SS4, a single-component, redox-responsive peptide coacervate system, as a biocompatible alternative for efficient mRNA delivery. By integrating glutathione-triggered disassembly and high encapsulation efficiency, the platform addresses biosafety and release challenges in RNA therapeutics.

• AZD3463: High-Affinity ALK/IGF1R Inhibitor for Neuroblastoma

  2026-05-06

  AZD3463 is a potent, orally bioavailable ALK/IGF1R inhibitor with nanomolar affinity that suppresses neuroblastoma cell proliferation and induces apoptosis through PI3K/AKT/mTOR pathway inhibition. It exhibits activity against both wild-type and mutant ALK, and enhances the efficacy of chemotherapeutic agents in vitro and in vivo. This product dossier provides a structured analysis of the evidence, practical workflow parameters, and key boundaries for translational research.

• Sumatriptan Succinate: Experimental Workflows for Migraine R

  2026-05-05

  Sumatriptan Succinate stands out as a robust 5-HT1 receptor agonist for dissecting serotonergic and neuroinflammatory pathways. This article details optimized research protocols, advanced applications, and troubleshooting strategies that empower translational and bench scientists alike.

16327 records 1/1089 page Next 12345 下5页 Last page